Results 21-40 of 215 for drugs speaker:David Cullinane

Written Answers — Department of Health: Departmental Data (14 Jun 2022)

David Cullinane: 1626. To ask the Minister for Health the estimated cost of permanently reducing the drugs payment scheme threshold from €100 to €60 in increments of €5. [29860/22]

Written Answers — Department of Health: Medicinal Products (26 Apr 2022)

David Cullinane: 1807. To ask the Minister for Health the status of the inquiry and terms of reference for the drug sodium valproate; his plans to provide the disability package for those affected by sodium valproate; and if he will make a statement on the matter. [21053/22]

Written Answers — Department of Health: Departmental Reports (22 Mar 2022)

David Cullinane: 1088. To ask the Minister for Health if his Department has completed the review of a report (details supplied) in respect of the drug reimbursement process; when this report and the key recommendations are expected to be published; and if he will make a statement on the matter. [15035/22]

Hospital Parking Bill 2021: Second Stage [Private Members] (17 Feb 2022)

David Cullinane: ...reforms. We promised that we would look at reducing the cost of healthcare, and removing car parking charges is one of those issues. In addition, I would like prescription charges to be abolished. I would also like further changes to the drugs payment scheme threshold. By the way, I welcome the cut introduced by the Government as part of the cost-of-living measures. The monthly...

Healthcare (Transparent Payments) Bill 2022: First Stage (2 Feb 2022)

David Cullinane: ...shows that in other jurisdictions, payments and gifts from the pharmaceutical industry are associated with higher prescribing rates and costs for certain products, increased use of specific drug classes and products and lower prescribing quality. The opioid crisis in the United States, fuelled by payments, gifts and misleading information from a pharmaceutical corporation to prescribers,...

Written Answers — Department of Health: Medicinal Products (1 Feb 2022)

David Cullinane: 687. To ask the Minister for Health if either the drug xonvea or cariban will be reimbursed for pregnant women suffering nausea and hyperemesis which does not respond to conservative management; and if he will make a statement on the matter. [4516/22]

Written Answers — Department of Health: Medicinal Products (1 Feb 2022)

David Cullinane: 745. To ask the Minister for Health if he has considered including cariban (details supplied) on the medical card and drug payment scheme; and if he will make a statement on the matter. [4833/22]

Written Answers — Department of Health: Medicinal Products (8 Dec 2021)

David Cullinane: 164. To ask the Minister for Health the cost of adding menopause medicine treatments by type to the drug payment scheme; and if he will make a statement on the matter. [60741/21]

Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2021: Second Stage [Private Members] (3 Dec 2021)

David Cullinane: ...in medicines and healthcare. We are seeing a lot of groundbreaking treatments, all of which are to be welcomed. Many new medicines have come on stream, including a large number of high-tech drugs, especially in the area of cancer, as well as huge advances in technology in regard to precision treatment and gene therapies. Many of these treatments require high-tech drugs, including orphan...

Written Answers — Department of Health: Departmental Funding (23 Nov 2021)

David Cullinane: 678. To ask the Minister for Health the way the €30 million announced in Budget 2022 for new drugs will be allocated; the sub-allocation to measures within this new measures grouping in tabular form; the amount remaining unallocated; the amount which relates to other new measures funding group commitments; if this is included as a whole or pro-rata; and if he will make a statement on...

Written Answers — Department of Health: Departmental Funding (23 Nov 2021)

David Cullinane: 685. To ask the Minister for Health the way the €6 million announced in budget 2022 for the national drugs strategy will be allocated; the sub-allocation to measures within this new measures grouping in tabular form; the amount remaining unallocated; the amount which relates to other new measures funding group commitments; if this is included as a whole or pro-rata; and if he will make...

Joint Oireachtas Committee on Health: Medical Cannabis Access Programme Update: Discussion (29 Sep 2021)

David Cullinane: ...will be available as a start for a programme as important as this is? We do not know how many products will be available next year and we do not know how many patients will be prescribed the drug this year or next year. This is not painting a good picture. There is not much information, it would seem, that I can give to the public or that will be given to the public arising from this...

Joint Oireachtas Committee on Health: Medical Cannabis Access Programme Update: Discussion (29 Sep 2021)

David Cullinane: My time is limited. I say again this is something that has to be done. I know there is a process but we need to look at the process. The drug approval process needs to be overhauled. It will go to the drugs group which will have to do its work. As Mr. Flanagan said, it will be sometime next year, and we do not know when, before a decision will be made on it. We are still some time away...

Written Answers — Department of Health: Health Services (9 Sep 2021)

David Cullinane: 1447. To ask the Minister for Health the estimated cost of reducing the drugs payment scheme threshold to €100; the estimated cost of reducing same in increments of €15; and if he will make a statement on the matter. [43088/21]

Written Answers — Department of Health: Medicinal Products (27 Jul 2021)

David Cullinane: 1479. To ask the Minister for Health when the review of the HSE drug reimbursement process will be published; and if he will make a statement on the matter. [33532/21]

Written Answers — Department of Health: Cannabis for Medicinal Use (27 Jul 2021)

David Cullinane: ...for Health further to Parliamentary Question No. 111 of 29 April 2021, if any of the four products referenced as accepted for use in the MCAP no longer meet the definition of a specified controlled drug post-Brexit; if, this will have any bearing on their supply in this State given they have already been accepted; and if he will make a statement on the matter. [33537/21]

Written Answers — Department of Health: Departmental Schemes (27 Jul 2021)

David Cullinane: 1811. To ask the Minister for Health the estimated cost of reducing the drugs payment scheme threshold to €100; the estimated cost of reducing same in increments of €15; and if he will make a statement on the matter. [35552/21]

Written Answers — Department of Justice and Equality: An Garda Síochána (22 Jun 2021)

David Cullinane: 499. To ask the Tánaiste and Minister for Justice and Equality the number of gardaí by rank attached to the Waterford divisional drugs unit as of 30 June 2020 and 14 June 2021, in tabular form; and if she will make a statement on the matter. [33119/21]

Covid-19 Vaccine Roll-out: Statements (27 May 2021)

David Cullinane: .... The first concerns medical cardholders whose cards are due to expire. Due to the fact they cannot get the cards renewed as a consequence of the cyberattack, pharmacists are not dispensing the drugs, which is obviously a real difficulty. Second, is there any update on patient or staff data breaches yet? Is there any update from those who are examining the systems as to the level of...